Skip Navigation
United States Flag

An official website of the United States government. Here's how you know >

A New Look for HHS-OIG. Learn More >>

Change Font Size


Special Advisory Bulletins

Special Advisory Bulletin: Pharmaceutical Manufacturer Copayment Coupons
Supplemental Special Advisory Bulletin: Independent Charity Patient Assistance Programs
Updated Special Advisory Bulletin on the Effect of Exclusions From Participation in Federal Health Programs
Special Advisory Bulletin: Average Manufacturer Price and Average Sales Price Reporting Requirements
Special Advisory Bulletin: Patient Assistance Programs for Medicare Part D Enrollees
Text of Letter From Michael O. Leavitt, Secretary of Health and Human Services, to the Honorable Billy Tauzin, President and CEO The Pharmaceutical Research and Manufacturers of America, Concerning Patient Assistance Programs
CMS Perspective on Pharmaceutical Company Patient Assistance Programs
Special Advisory Bulletin: Contractual Joint Ventures
Special Advisory Bulletin: Offering Gifts and Other Inducements To Beneficiaries
Special Advisory Bulletin: Practices of Business Consultants
Special Advisory Bulletin: Patient Anti-Dumping Statute
Special Advisory Bulletin: The Effect of Exclusion From Participation in Federal Health Care Programs
Press Release
OIG letter regarding hospital-physician incentive plans for Medicare and Medicaid beneficiaries enrolled in managed care plans
Gainsharing Arrangements and CMPs for Hospital Payments to Physicians to Reduce or Limit Services to Beneficiaries
Recent Commentary Distorts HHS IG's Gainsharing Bulletin
Solicitation of Comments on the OIG/HCFA Special Advisory Bulletin on the Patient Anti-Dumping Statute

Medicare Bulletins

What Medicare Beneficiaries Need to Know About Health Maintenance Organizations
Publication of the Medicare Advisory Bulletin on Hospice Benefits

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201